HS OBTAIN vVARY
THREADDownload Options
Screenshots
/
About this app
App for assessing the efficacy and safety of SAR442970 in moderate to severe HS.
Your app for the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
Version Information
- Version
- -
- Downloads
- 50+
- Updated on
- -
- Released
- Oct 2, 2023
- Requires
- Android Varies with device
Ratings & Reviews
Developer Response